bortezomib
(Bortezomib)Novadoz Pharmaceuticals LLC
Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
7 results
bortezomib
(BORTEZOMIB)Hospira, Inc.Usage: Bortezomib for Injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.bortezomib
(bortezomib)Hikma Pharmaceuticals USA Inc.Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.bortezomib
(Bortezomib)NorthStar RxLLCUsage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.boruzu
(Bortezomib)Amneal Pharmaceuticals LLCUsage: BORUZU is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.lenalidomide
(Lenalidomide)Biocon Pharma Inc.Usage: Lenalidomide is indicated for treating multiple myeloma (MM) in combination with dexamethasone, as maintenance therapy post-autologous stem cell transplantation, and for transfusion-dependent anemia due to myelodysplastic syndromes. It's also used for relapsed mantle cell lymphoma and in combination with rituximab for follicular and marginal zone lymphomas.lenalidomide
(lenalidomide)Cipla USA Inc.Usage: Lenalidomide capsules are indicated for treating adult patients with multiple myeloma (in combination with dexamethasone or as maintenance therapy post-transplant), myelodysplastic syndromes, mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma (with rituximab). Not recommended for chronic lymphocytic leukemia outside clinical trials.